乳腺癌治疗临床试验中的单克隆抗体
Rahaman Shaik1, Varikuppala Mounika2, Shireen Begum2
1School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India.
概括
单克隆抗体 (mAbs) 在乳腺癌 (BC) 检测和治疗方面表现有前途,特别是在HER2阳性类型中. 尽管存在潜在的副作用,但对三阴性乳腺瘤仍需要进一步的研究.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 单克隆抗体 (mAbs) 是现代医学中至关重要的工具,特别是用于癌症治疗和诊断.
- 在乳腺癌 (BC) 中,mAbs 向癌细胞,输送药物,抑制生长,调节免疫系统.
研究的目的:
- 审查单克隆抗体在乳腺癌检测和治疗中的当前和未来应用.
- 突出使用mAbs用于各种乳腺癌亚型的优缺点.
主要方法:
- 在乳腺癌中应用单克隆抗体的文献综述.
- 分析mAbs的有效性和局限性,包括双特异和三特异格式.
- 检查与mAb疗法相关的不良影响.
主要成果:
- mAbs对HER2阳性乳腺癌非常有效,但在三阴性乳腺癌中没有得到充分的研究.
- 双特异和三特异的mAbs提供了增强的向疗效和多功能性.
- 常见的副作用包括发烧,疲劳,恶心,以及可能出现皮疹或出血.
结论:
- 单克隆抗体是乳腺癌的重要治疗策略,目前正在开发更广泛的应用.
- 解决局限性和副作用对于优化mAb治疗至关重要.
- 未来的研究应该专注于扩大mAb在不同类型的乳腺癌中的效用,包括三阴性乳腺癌.
- 双特异性和三特异性抗体显示出改善治疗结果的希望.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K